vs

Side-by-side financial comparison of Cytosorbents Corp (CTSO) and Red Cat Holdings, Inc. (RCAT). Click either name above to swap in a different company.

Red Cat Holdings, Inc. is the larger business by last-quarter revenue ($9.6M vs $9.2M, roughly 1.0× Cytosorbents Corp). Cytosorbents Corp runs the higher net margin — -59.5% vs -166.0%, a 106.5% gap on every dollar of revenue. On growth, Red Cat Holdings, Inc. posted the faster year-over-year revenue change (988.2% vs 0.9%). Cytosorbents Corp produced more free cash flow last quarter ($-4.9M vs $-24.5M).

CytoSorbents Corporation is a publicly traded company located in Princeton, New Jersey.

Mega Cat Studios is an American video game development and publishing company located in Pittsburgh, Pennsylvania. It was founded in 2015 by James Deighan, Nick Mann, and Zack Manko.

CTSO vs RCAT — Head-to-Head

Bigger by revenue
RCAT
RCAT
1.0× larger
RCAT
$9.6M
$9.2M
CTSO
Growing faster (revenue YoY)
RCAT
RCAT
+987.3% gap
RCAT
988.2%
0.9%
CTSO
Higher net margin
CTSO
CTSO
106.5% more per $
CTSO
-59.5%
-166.0%
RCAT
More free cash flow
CTSO
CTSO
$19.6M more FCF
CTSO
$-4.9M
$-24.5M
RCAT

Income Statement — Q4 FY2025 vs Q3 FY2025

Metric
CTSO
CTSO
RCAT
RCAT
Revenue
$9.2M
$9.6M
Net Profit
$-5.5M
$-16.0M
Gross Margin
73.7%
6.6%
Operating Margin
-47.5%
-181.7%
Net Margin
-59.5%
-166.0%
Revenue YoY
0.9%
988.2%
Net Profit YoY
27.4%
-29.0%
EPS (diluted)
$-0.09
$-0.16

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CTSO
CTSO
RCAT
RCAT
Q4 25
$9.2M
Q3 25
$9.5M
$9.6M
Q2 25
$9.6M
Q1 25
$8.7M
$1.6M
Q4 24
$9.2M
$0
Q3 24
$8.6M
Q2 24
$8.8M
Q1 24
$9.0M
$5.8M
Net Profit
CTSO
CTSO
RCAT
RCAT
Q4 25
$-5.5M
Q3 25
$-3.2M
$-16.0M
Q2 25
$1.9M
Q1 25
$-1.5M
$-23.1M
Q4 24
$-7.6M
$-13.3M
Q3 24
$-2.8M
Q2 24
$-4.3M
Q1 24
$-6.1M
$-5.5M
Gross Margin
CTSO
CTSO
RCAT
RCAT
Q4 25
73.7%
Q3 25
70.3%
6.6%
Q2 25
70.9%
Q1 25
71.1%
-52.2%
Q4 24
68.4%
Q3 24
61.0%
Q2 24
73.5%
Q1 24
76.5%
18.8%
Operating Margin
CTSO
CTSO
RCAT
RCAT
Q4 25
-47.5%
Q3 25
-30.2%
-181.7%
Q2 25
-37.6%
Q1 25
-44.5%
-765.7%
Q4 24
-37.1%
Q3 24
-56.1%
Q2 24
-40.4%
Q1 24
-51.8%
-76.0%
Net Margin
CTSO
CTSO
RCAT
RCAT
Q4 25
-59.5%
Q3 25
-33.4%
-166.0%
Q2 25
20.2%
Q1 25
-16.9%
-1418.9%
Q4 24
-82.7%
Q3 24
-32.1%
Q2 24
-48.6%
Q1 24
-67.7%
-93.9%
EPS (diluted)
CTSO
CTSO
RCAT
RCAT
Q4 25
$-0.09
Q3 25
$-0.05
$-0.16
Q2 25
$0.03
Q1 25
$-0.02
$-0.27
Q4 24
$-0.14
Q3 24
$-0.05
Q2 24
$-0.08
Q1 24
$-0.11

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CTSO
CTSO
RCAT
RCAT
Cash + ST InvestmentsLiquidity on hand
$6.2M
Total DebtLower is stronger
Stockholders' EquityBook value
$5.9M
$253.3M
Total Assets
$44.2M
$286.0M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CTSO
CTSO
RCAT
RCAT
Q4 25
$6.2M
Q3 25
$7.5M
Q2 25
$10.2M
Q1 25
$11.6M
Q4 24
$3.3M
Q3 24
$5.7M
Q2 24
$8.5M
Q1 24
$8.6M
Total Debt
CTSO
CTSO
RCAT
RCAT
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
$13.8M
Q2 24
$13.7M
Q1 24
$4.4M
Stockholders' Equity
CTSO
CTSO
RCAT
RCAT
Q4 25
$5.9M
Q3 25
$9.0M
$253.3M
Q2 25
$11.6M
Q1 25
$14.5M
$28.9M
Q4 24
$11.1M
$27.0M
Q3 24
$13.4M
Q2 24
$17.4M
Q1 24
$19.6M
$49.6M
Total Assets
CTSO
CTSO
RCAT
RCAT
Q4 25
$44.2M
Q3 25
$45.8M
$286.0M
Q2 25
$48.0M
Q1 25
$50.8M
$59.7M
Q4 24
$47.4M
$51.1M
Q3 24
$47.8M
Q2 24
$53.4M
Q1 24
$47.1M
$55.3M
Debt / Equity
CTSO
CTSO
RCAT
RCAT
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
1.03×
Q2 24
0.78×
Q1 24
0.23×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CTSO
CTSO
RCAT
RCAT
Operating Cash FlowLast quarter
$-4.8M
$-23.9M
Free Cash FlowOCF − Capex
$-4.9M
$-24.5M
FCF MarginFCF / Revenue
-53.4%
-254.2%
Capex IntensityCapex / Revenue
1.2%
6.9%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-12.5M
$-55.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CTSO
CTSO
RCAT
RCAT
Q4 25
$-4.8M
Q3 25
$-2.6M
$-23.9M
Q2 25
$-1.5M
Q1 25
$-3.5M
$-15.9M
Q4 24
$-2.3M
$-10.1M
Q3 24
$-2.5M
Q2 24
$-4.8M
Q1 24
$-4.8M
$-4.1M
Free Cash Flow
CTSO
CTSO
RCAT
RCAT
Q4 25
$-4.9M
Q3 25
$-2.6M
$-24.5M
Q2 25
$-1.5M
Q1 25
$-3.5M
$-16.2M
Q4 24
$-2.4M
$-10.2M
Q3 24
$-2.6M
Q2 24
$-4.8M
Q1 24
$-4.9M
$-4.2M
FCF Margin
CTSO
CTSO
RCAT
RCAT
Q4 25
-53.4%
Q3 25
-27.3%
-254.2%
Q2 25
-16.1%
Q1 25
-39.7%
-992.9%
Q4 24
-26.3%
Q3 24
-30.4%
Q2 24
-54.4%
Q1 24
-54.2%
-71.1%
Capex Intensity
CTSO
CTSO
RCAT
RCAT
Q4 25
1.2%
Q3 25
0.2%
6.9%
Q2 25
0.4%
Q1 25
0.0%
16.8%
Q4 24
0.8%
Q3 24
1.8%
Q2 24
0.2%
Q1 24
0.5%
0.8%
Cash Conversion
CTSO
CTSO
RCAT
RCAT
Q4 25
Q3 25
Q2 25
-0.78×
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CTSO
CTSO

Direct$5.1M55%
Distributors And Strategic Partners$4.2M45%

RCAT
RCAT

Products$8.5M88%
Services$1.2M12%

Related Comparisons